Matthias Bodenstedt - Chief Financial Officer at MoonLake Immunotherapeutics

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Financial Officer
Issuer Symbol
MLTX on Nasdaq
All Insider Reports
All Insider Reports

Matthias Bodenstedt - trading volume in the past year for MoonLake Immunotherapeutics

Holdings reported by Matthias Bodenstedt for MoonLake Immunotherapeutics

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Class A ordinary shares, par value $0.0001 per share 1,276,305 $16,807,660 $13.17 07 Jan 2026 Direct
Class C ordinary shares, par value $0.0001 per share 0 19 Dec 2025 Direct
Common shares, par value CHF 0.10 per share, of MoonLake AG 0 19 Dec 2025 Direct Class A ordinary shares, par value $0.0001 per share

Transactions reported by Matthias Bodenstedt for MoonLake Immunotherapeutics

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.